Consumer Beware: A Systematic Assessment of Potential Bias in the Lay Electronic Media to Examine the Portrayal of “PARP” Inhibitors for Cancer Treatment

Por Coleman, Shawnta, Peethambaram, Prema P., Jatoi, Aminah
Publicado em 2011

Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia

Por Kasi, Pashtoon Murtaza, Patnaik, Mrinal M., Peethambaram, Prema P.
Publicado em 2013

Self-Perceptions of Age among 292 Chemotherapy-Treated Cancer Patients: Exploring Associations with Symptoms and Survival

Por Lim, Ming Y., Stephens, Elisabeth K., Novotny, Paul, Price, Katharine, Salayi, Marcia, Roeker, Lindsey, Peethambaram, Prema, Jatoi, Aminah
Publicado em 2013

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study

Por Peethambaram, Prema P., Hoskin, Tanya L., Day, Courtney N., Goetz, Matthew P., Habermann, Elizabeth B., Boughey, Judy C.
Publicado no NPJ Breast Cancer (2017)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer

Por Haddad, Tufia C., D’Assoro, Antonino, Suman, Vera, Opyrchal, Mateusz, Peethambaram, Prema, Liu, Minetta C., Goetz, Matthew P., Ingle, James N.
Publicado no Breast Cancer Res Treat (2017)

Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients with Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma

Por Weroha, S. John, Oberg, Ann L., Allen Ziegler, Katie L., Dakhilm, Shaker R., Rowland, Kendrith M., Hartmann, Lynn C., Moore, Dennis F., Keeney, Gary L., Peethambaram, Prema P., Haluska, Paul
Publicado em 2011

A Phase II Study of Gemcitabine in Combination with Tanespimycin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma

Por Wahner Hendrickson, Andrea E., Oberg, Ann L., Glaser, Gretchen, Camoriano, John K., Peethambaram, Prema P., Colon-Otero, Gerardo, Erlichman, Charles, Ivy, Percy, Kaufmann, Scott H., Karnitz, Larry M., Haluska, Paul
Publicado em 2011

A Phase 1 Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu

Por Peethambaram, Prema P., Melisko, Michelle E., Rinn, Kristine J., Alberts, Steven R., Provost, Nicole M., Jones, Lori A., Sims, Robert B., Lin, Lisa R.C., Frohlich, Mark W., Park, John W.
Publicado em 2009

Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome

Por Peethambaram, Prema, Fridley, Brooke L, Vierkant, Robert A, Larson, Melissa C, Kalli, Kimberly R, Elliott, Elaine A, Oberg, Ann L, White, Kristin L, Rider, David N, Keeney, Gary L, Cunningham, Julie M, Hartmann, Lynn C, Goode, Ellen L
Publicado em 2011

A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261

Por Bible, Keith C., Peethambaram, Prema P., Oberg, Ann L., Maples, William, Groteluschen, David L., Boente, Matthew, Burton, Jill K., Gomez Dahl, Leigh C., Tibodeau, Jennifer D., Isham, Crescent R., Maguire, Jacie L., Shridhar, Viji, Kukla, Andrea K., Voll, Kalli J., Mauer, Mathew J., Colevas, Alexander D., Wright, John, Doyle, L. Austin, Erlichman, Charles
Publicado em 2012

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Por Galanis, Evanthia, Hartmann, Lynn C., Cliby, William A., Long, Harry J., Peethambaram, Prema P., Barrette, Brigitte A., Kaur, Judith S., Haluska, Paul J., Aderca, Ileana, Zollman, Paula J., Sloan, Jeff A., Keeney, Gary, Atherton, Pamela J., Podratz, Karl C., Dowdy, Sean C., Stanhope, C. Robert, Wilson, Timothy O., Federspiel, Mark J., Kah-Whye, Peng, Russell, Stephen J.
Publicado em 2010

Inherited Determinants of Ovarian Cancer Survival

Por Goode, Ellen L., Maurer, Matthew J., Sellers, Thomas A., Phelan, Catherine M., Kalli, Kimberly R., Fridley, Brooke L., Vierkant, Robert A., Armasu, Sebastian M., White, Kristin L., Keeney, Gary L., Cliby, William A., Rider, David N., Kelemen, Linda E., Jones, Monica B., Peethambaram, Prema P., Lancaster, Johnathan M., Olson, Janet E., Schildkraut, Joellen M., Cunningham, Julie M., Hartmann, Lynn C.
Publicado em 2010

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Por Yadav, Siddhartha, Hu, Chunling, Hart, Steven N., Boddicker, Nicholas, Polley, Eric C., Na, Jie, Gnanaolivu, Rohan, Lee, Kun Y., Lindstrom, Tricia, Armasu, Sebastian, Fitz-Gibbon, Patrick, Ghosh, Karthik, Stan, Daniela L., Pruthi, Sandhya, Neal, Lonzetta, Sandhu, Nicole, Rhodes, Deborah J., Klassen, Christine, Peethambaram, Prema P., Haddad, Tufia C., Olson, Janet E., Hoskin, Tanya L., Goetz, Matthew P., Domchek, Susan M., Boughey, Judy C., Ruddy, Kathryn J., Couch, Fergus J.
Publicado no J Clin Oncol (2020)

Assessment of hepatocyte growth factor in ovarian cancer mortality

Por Goode, Ellen L., Chenevix-Trench, Georgia, Hartmann, Lynn C., Fridley, Brooke L., Kalli, Kimberly R., Vierkant, Robert A., Larson, Melissa C., White, Kristin L., Keeney, Gary L., Oberg, Trynda N., Cunningham, Julie M., Beesley, Jonathan, Johnatty, Sharon E., Chen, Xiaoqing, Goodman, Katelyn E., Armasu, Sebastian M., Rider, David N., Sicotte, Hugues, Schmidt, Michele M., Elliott, Elaine A., Høgdall, Estrid, Kjær, Susanne Krüger, Fasching, Peter A., Ekici, Arif B., Lambrechts, Diether, Despierre, Evelyn, Høgdall, Claus, Lundvall, Lene, Karlan, Beth Y., Gross, Jenny, Brown, Robert, Chien, Jeremy, Duggan, David J., Tsai, Ya-Yu, Phelan, Catherine M., Kelemen, Linda E., Peethambaram, Prema P., Schildkraut, Joellen M., Shridhar, Vijayalakshmi, Sutphen, Rebecca, Couch, Fergus J., Sellers, Thomas A.
Publicado em 2011